Portfolio scale Qosina offers an extensive catalog of over 5,000 single-use, off-the-shelf components with on-hand inventory and just-in-time delivery, presenting a ready-made opportunity to cross-sell to medical device and bioprocess manufacturers seeking reliable supply for prototype through production stages.

Regulatory credibility With ISO 13485, ISO 9001, ISO 22301 and ISO 14001 certifications, Qosina demonstrates quality, continuity, and change control, making them a trusted supplier for customers needing compliant components for vaccines, cell therapy, and other regulated applications.

Strategic partnerships Ongoing collaborations and events with Packaging Compliance Labs, Informa Markets, and industry shows (INTERPHEX, COMPAMED) indicate a mature channel strategy and opportunities to co-market, co-host trainings, or sponsor education to capture engineers and procurement leads.

Innovation drive Regular product updates including a January 2026 New Product Preview featuring hundreds of new components, plus design and development services, present upsell opportunities to customers pursuing new device iterations, bioprocess upgrades, or customization needs.

Customer enablement Low minimum orders, free samples, 3D CAD models, BOM kitting, and modification of existing molds reduce friction for onboarding and expand potential for incremental sales across prototype-to-production programs and OEM collaboration.